Morning-Outlook-Feature-Image

Morning-outlook-4nov

NIFTY:

The NIFTY opened at 17968.35 with a big gap down of 114 points. The index rebounded quickly and started moving on the upside after recordings its intraday low at 17959.20. A sharp rally from the opening brought the index above 18100 and prices recorded its intraday high at 18106.30. The NIFTY moved down afterward and then started a consolidation process. Prices have finally dosed at 18052.70 with a loss of 30.15 points or 0.17% down. REALTY outperformed today followed by BANK and FMCG. IT underperformed today and ended with a loss of 1.18%. FINANCIAL and PHARMA ended on a flat note. The NIFTY has seen four days of sharp rally and has paused for the past two trading days. We should be buyers as far as prices are trading above 18000 support. Resistance is visible around 18600 which is also the lifetime high for the NIFTY Index. We have been expecting a dip or a few days of consolidation. We should now wait patiently for an adequate trading setup to suggest a trade. Buying should be down on a breakout or a dip while shorting opportunities may emerge on a close below 16800. As of now, avoid trading the index.

BANK NIFTY:

The BANK NIFTY opened at 40873.70 with a big gap down of 234 points. The index bounced up from the start and filled the gap quickly. Prices recorded its intraday low at 40819.15 and rallied over 5OO points to record its intraday high at 41478. However, prices then started moving sideways and finally closed at 41304.6S with a gain of 197 points. PSU BANKS have outperformed today by closing 2.52% higher while PVT BANKS have also seen a rally today but closed with a gain of just 0.34%. Within the index, In terms of points, SBIN contributed the highest on the upside while HDFC BANK contributed the lowest. Look for a buying opportunity on a breakout above 41500 or a shorting opportunity on a break down below 40800. In case of a gap beyond these levels follow the first 5 minutes rule. Keep a stop of 300 points and a target of 800 points. A gap-down opening did not sustain today in the BANK Index. Prices have seen a sharp intraday rally and ended with gains. The index continued moving inside a narrow range with 40800 support and 41700 resistance for the past eight trading days. A breakout from this range may give us a directional move.

TECHNICAL PICKS

COMPANY NAME CMP B/S RATIONALE
SBI LIFE 1276.05 BUY The stock is on the verge of giving a breakout on the intraday as well as the daily chart. The stock can be bought at CMP with a stop loss of 1267 and a target of  1296.
BALKRISHNA IND 1895.60 SELL The stock has given the breakdown on the intraday as well as the daily chart. The stock can be sold at CMP with a stop loss of 1915 and for a target of 1862.

DERIVATIVE PICKS

Stock Name Strike Price Buy/Sell CMP Initiation Stop Loss Target Remarks
BPCL 310 CE BUY 6.90 CMP 5.90 8.90 BREAKOUT
Long Buildup Short Buildup
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
M&MFIN.22.11 Nov 218.85 14.61 14.1 28352000 VOLTAS.22.11 Nov 863.65 -5.62 46.86 5752500
PEL.22.11 Nov 899.2 7.05 2.57 5333075 BALKRISIND.22.11 Nov 1900.95 -3.16 10.54 2303700
DALBHARAT.22.11 Nov 1664.5 4.07 18.22 1557500 INTELLECT.22.11 Nov 415.05 -2.66 5 3872250
BIOCON.22.11 Nov 281 4.02 1.11 26397100 TECHM.22.11 Nov 1041.95 -2.48 7.78 13681800
COROMANDEL2211No 1009.95 3.77 63.08 2448600 IPCALAB.22.11 Nov 908.65 -2.46 4.36 1370200
                                                                        Short Covering                                                                       Long Unwinding
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
PNB.22.11 Nov 41.55 5.46 -5.07 2.37E+08 NTPC.22.11 Nov 179.25 -1.16 -0.72 49504500
CANFINHOME2211Nov 524.8 3.08 -1.37 4490850 GUJGASLTD.22.11 Nov 518.65 -0.87 -1.78 4818750
SRTRANSFIN.22.11 Nov 1239.05 2.74 -1.42 3584400 SUNPHARMA.22.11 Nov 1052.65 -0.55 -0.06 19789700
BEL.22.11 Nov 110.35 2.46 -0.47 79497900 METROPOLIS.22.11 Nov 1675.85 -0.48 -0.61 788100
ABCAPITAL.22.11 Nov 120.75 1.94 -1.18 22129200 PIIND.22.11 Nov 3260.15 -0.29 -0.67 1658500

TOP DELIVERY PERCENTAGE

Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Quantity
Biocon Limited 279.75 4.21 5298720 0 78.58 Nifty50 18052.7 -0.17 83940
Bosch Limited 16557.9 -0.12 19015 0 73.59 Niftybank 41298.35 0.37 83940
Hdfc Ltd. 2489.4 -0.74 2582845 0 72.99 Nifty it 28795.75 -1.18 83940
Kotak Mahindra Bank Limi 1900.15 -0.51 1591871 0 70.17 India Vix 15.94 -4.32 83940
Piind 3245.55 -0.38 165807 0 70.16 Nifty Fmcg 44661.85 0.29 83940
Power Grid Corporation o 228.05 -2.25 7018662 0 69.12 Nifty Pharma 13559.95 0.02 83940
Tata Consultancy Serv Lt 3206.75 -1.08 1422652 0 69.04 Nifty Realty 441.7 0.58 83940
Hdfc Bank Ltd. 1507.55 -0.44 5166176 0 67.86 Nifty Auto 13262.65 -0.42 83940
Vodafone Idea Limited 8.55 0 25842530 0 67.47 Nifty Metal 6068.75 -0.11 83940
Torrent Pharma Ltd. 1689.55 -0.28 216091 0 66.71 Nifty Financial Services 18582.25 0.03 83940

UPCOMING ECONOMIC DATA

   Domestic                                                                                                                                                  International
INR: FX Reserves, USD on 4th  November, 2022

INR: CPI (YoY) (Oct)on 11th  November, 2022

 USD: Unemployment Rate (Oct) on 4th  November, 2022

USD: Nonfarm Payrolls (Oct) on 4th  November, 2022

NEWS UPDATES

  • Indian benchmark indices ended marginally lower in the volatile session on November 3.At Close, the Sensex was down 69.68 points or 0.11% at 60,836.41, and the Nifty was down 30.10 points or 0.17% at 18,052.70. About 1725 shares have advanced, 1630 shares declined, and 120 shares are unchanged.

  • Five Star Business Finance Ltd’s investors are in shock after the company priced its initial public offering (IPO) below its unlisted market price, dealers said.The South-based lender’s share price is Rs 525-530 per share in the unlisted market while the IPO price band is fixed at Rs 450-474 per share, about 10.6 percent below the current unlisted price.

  • Share price of Adani Wilmar fell by 2 percent after the FMCG company posted a 73.3 percent on-year decline in consolidated net profit. The company’s post-tax profit came in at Rs 48.7 crore in the quarter ended September 2022 as against Rs 182.3 crore in the same quarter last fiscal

Source: Economic Times,  Indian Express, Business Today, Livemint, Business Standard, Bloomberg Quint

BOARD MEETINGS

Company Name Purpose Meeting Date Company Name Purpose Meeting Date
ABFRL Quarterly Results 04-Nov-22 KANPRPLA Quarterly Results;General 04-Nov-22
ABIRAFN Quarterly Results 04-Nov-22 KARTKIN Quarterly Results 04-Nov-22
ADESHWAR Half Yearly Results;General 04-Nov-22 KBCGLOBAL General 04-Nov-22
ADORMUL Quarterly Results 04-Nov-22 LAKSELEC Quarterly Results 04-Nov-22
ADORWELD Quarterly Results;General 04-Nov-22 MAHLOG Quarterly Results;General 04-Nov-22
AKZOINDIA Quarterly Results 04-Nov-22 MARALOVER Quarterly Results 04-Nov-22
AMARNATH Quarterly Results;General 04-Nov-22 MARICO Quarterly Results 04-Nov-22
AMRUTANJAN Interim Dividend;Quarterly Results 04-Nov-22 MENNPIS Quarterly Results 04-Nov-22
ARVSMART Quarterly Results;General 04-Nov-22 MERCANTILE Quarterly Results 04-Nov-22
BHAGCHEM Interim Dividend;Quarterly Results 04-Nov-22 METSL Quarterly Results 04-Nov-22
BHARATSE Quarterly Results 04-Nov-22 MINDACORP Quarterly Results 04-Nov-22
BRITANNIA Quarterly Results 04-Nov-22 MORARJEE Quarterly Results 04-Nov-22
CAMS Quarterly Results 04-Nov-22 MRP Half Yearly Results 04-Nov-22
CELEBRITY Quarterly Results 04-Nov-22 NAVA Quarterly Results 04-Nov-22
CGCL Right Issue of Equity Shares;Quarterly Results 04-Nov-22 NEH Quarterly Results;General 04-Nov-22
CHEMPLASTS Quarterly Results 04-Nov-22 NOL Quarterly Results 04-Nov-22
CIPLA Quarterly Results 04-Nov-22 NRAGRINDQ Quarterly Results 04-Nov-22
COCHMAL Quarterly Results 04-Nov-22 ORBTEXP Quarterly Results;Buy Back of Shares 04-Nov-22
COROENGG Quarterly Results 04-Nov-22 PARADEEP Quarterly Results 04-Nov-22
CUB Quarterly Results 04-Nov-22 PNC Quarterly Results 04-Nov-22
CUMMINSIND Quarterly Results 04-Nov-22 POLYMED Quarterly Results;General 04-Nov-22
DHARSUGAR Audited Results 04-Nov-22 POWERINDIA Quarterly Results 04-Nov-22
DREAMFOLKS Quarterly Results 04-Nov-22 PURVA Quarterly Results 04-Nov-22
EKI Quarterly Results 04-Nov-22 RAJSREESUG Quarterly Results 04-Nov-22
ELGIEQUIP Quarterly Results 04-Nov-22 RAMAPHO Quarterly Results 04-Nov-22
ESCORTS Quarterly Results 04-Nov-22 REMLIFE Quarterly Results 04-Nov-22
FCL Quarterly Results;General 04-Nov-22 RITESHIN Quarterly Results;General 04-Nov-22
GAIL Quarterly Results 04-Nov-22 SAFARIND Quarterly Results 04-Nov-22
GET&D Quarterly Results 04-Nov-22 SAGARSOFT Quarterly Results 04-Nov-22
GILLETTE Quarterly Results 04-Nov-22 SARDAPPR Quarterly Results;General 04-Nov-22
GOACARBON Quarterly Results 04-Nov-22 SCANSTL Quarterly Results 04-Nov-22
GOCOLORS Quarterly Results 04-Nov-22 SCI Quarterly Results 04-Nov-22
GODREJAGRO Quarterly Results 04-Nov-22 SELAN Quarterly Results 04-Nov-22
GRPLTD Quarterly Results 04-Nov-22 SHARMEH Quarterly Results 04-Nov-22
HARSHA Quarterly Results 04-Nov-22 SHBCLQ Quarterly Results 04-Nov-22
HELPAGE Quarterly Results 04-Nov-22 SOLARINDS Quarterly Results;General 04-Nov-22
HESTERBIO Quarterly Results 04-Nov-22 STLTECH Quarterly Results 04-Nov-22
HIL Quarterly Results 04-Nov-22 SUTLEJTEX Quarterly Results 04-Nov-22
HYBRIDFIN Quarterly Results 04-Nov-22 TATVA Quarterly Results 04-Nov-22
IDFCFIRSTB General 04-Nov-22 TIINDIA Quarterly Results 04-Nov-22
INDIGO Quarterly Results 04-Nov-22 TITAN Quarterly Results 04-Nov-22
INDRAMEDCO Quarterly Results 04-Nov-22 TTKPRESTIG Quarterly Results 04-Nov-22
INDTERRAIN Quarterly Results 04-Nov-22 TVSMOTOR Quarterly Results;General 04-Nov-22
INFIBEAM Quarterly Results;General 04-Nov-22 USHAKIRA Quarterly Results 04-Nov-22
INTLCOMBQ Quarterly Results 04-Nov-22 VENMAX Quarterly Results 04-Nov-22
ISMTLTD Quarterly Results 04-Nov-22 VFL Right Issue of Equity Shares;General 04-Nov-22
JAGRAN Buy Back of Shares;Quarterly Results 04-Nov-22 VINYOFL Quarterly Results 04-Nov-22
JAIMATAG Quarterly Results 04-Nov-22 VISAKAIND Quarterly Results 04-Nov-22
JAYATMA Quarterly Results 04-Nov-22 WOCKPHARMA Quarterly Results 04-Nov-22
JSWHL Quarterly Results 04-Nov-22 YASHO Quarterly Results 04-Nov-22
JUBLINDS Quarterly Results 04-Nov-22 ZFCVINDIA Quarterly Results 04-Nov-22

CORPORATE ACTION

Company Name Ex-Date Purpose Company Name Ex-Date Purpose
ALLSEC 04-Nov-22 Interim Dividend – Rs. – 20.0000 EPL 14-Nov-22 Interim Dividend
CRISIL 04-Nov-22 Interim Dividend – Rs. – 10.0000 JAMNAAUTO 14-Nov-22 Interim Dividend – Rs. – 0.8000
DHANBANK 04-Nov-22 E.G.M. NICCOPAR 14-Nov-22 Interim Dividend
KKCL 04-Nov-22 Interim Dividend – Rs. – 3.0000 PGINVIT 14-Nov-22 Income Distribution (InvIT)
MANAS 04-Nov-22 E.G.M. POWERGRID 14-Nov-22 Interim Dividend
PGHH 04-Nov-22 Final Dividend – Rs. – 65.0000 SMCGLOBAL 14-Nov-22 Interim Dividend
TCIEXP* 04-Nov-22 Interim Dividend – Rs. – 3.0000 AEGISLOG 15-Nov-22 Interim Dividend
TFL 04-Nov-22 Right Issue of Equity Shares GLOSTERLTD 15-Nov-22 Interim Dividend
RECLTD 07-Nov-22 Interim Dividend – Rs. – 5.0000 MODIS 15-Nov-22 Bonus issue 3:1
SPLPETRO 07-Nov-22 Interim Dividend – Rs. – 4.0000 PGHL 15-Nov-22 Final Dividend – Rs. – 11.5000
SUPREMEIND 07-Nov-22 Interim Dividend – Rs. – 6.0000 BHAGCHEM 16-Nov-22 Interim Dividend
IMAGICAA 09-Nov-22 E.G.M. QGO 16-Nov-22 Interim Dividend
PUNITCO 09-Nov-22 Bonus issue 5:1 GABRIEL 17-Nov-22 Interim Dividend
TECHM 09-Nov-22 Special Dividend – Rs. – 18.0000 GRINFRA 17-Nov-22 Interim Dividend
DAAWAT 10-Nov-22 Interim Dividend – Rs. – 0.5000 MRF 17-Nov-22 Interim Dividend
DALBHARAT 10-Nov-22 Interim Dividend – Rs. – 4.0000 PAGEIND 17-Nov-22 Interim Dividend
GILLETTE 10-Nov-22 Final Dividend – Rs. – 36.0000 QUESS 17-Nov-22 Interim Dividend
NYKAA 10-Nov-22 Bonus issue 5:1 ASTRAL 18-Nov-22 Interim Dividend
SHAREINDIA 10-Nov-22 Interim Dividend – Rs. – 2.0000 EMAMILTD 18-Nov-22 Interim Dividend
SSWL 10-Nov-22 Stock  Split From Rs.5/- to Rs.1/- ESABINDIA 18-Nov-22 Interim Dividend
AJANTPHARM 11-Nov-22 Interim Dividend IRFC 18-Nov-22 Interim Dividend
GMM 11-Nov-22 Interim Dividend MAANALU 18-Nov-22 Interim Dividend
SAMOR 11-Nov-22 Right Issue of Equity Shares NAUKRI 18-Nov-22 Interim Dividend
SIYSIL 11-Nov-22 Interim Dividend MAZDOCK 21-Nov-22 Interim Dividend
AMRUTANJAN 14-Nov-22 Interim Dividend TIDEWATER 21-Nov-22 Interim Dividend
ARFIN 14-Nov-22 Stock  Split From Rs.10/- to Rs.1/- IPCALAB 22-Nov-22 Interim Dividend

 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL